Medicine guide
APRETUDE
As listed in the register: APRETUDE 600 mg, suspension injectable à libération prolongée
600 mg · suspension injectable à libération prolongée
- Prescription only
- Active substance
- Cabotégravir
- Made by
- VIIV HEALTHCARE (PAYS-BAS)
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | VIIV HEALTHCARE (PAYS-BAS) |
|---|---|
| Active substance | Cabotégravir |
| Strength | 600 mg |
| Form | suspension injectable à libération prolongée |
| Route | intramusculaire |
| Dispensing (as stated by the register) | liste I |
| Marketed | Yes, according to the register |
| Reinforced monitoring | Yes — under reinforced monitoring, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/23/1760 |
| Name in the register | APRETUDE 600 mg, suspension injectable à libération prolongée |
| Packs | 1 flacon(s) en verre brun de 3 ml |
| CIS | 62595850 |
| CIP13 | 3400930278994 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.